by | Jul 21, 2025 | Lupus Foundation of America
The 340B Drug Pricing Program was started in 1992 by Congress to help offset the costs of providing medications to low-income patients by allowing certain hospitals to purchase prescription drugs at significantly discounted prices. Over the past 15 years the program...
by | Jul 3, 2025 | Lupus Foundation of America
Today, the House of Representatives passed H.R. 1, the One Big Beautiful Bill Act, and sent the legislation to the President for his signature. “We are disappointed that members of Congress failed to remove the significant cuts to Medicaid funding included in this...
by | Jul 1, 2025 | Lupus Foundation of America
Today, the Lupus Foundation of America and a coalition of leading national patient advocacy organizations issued a statement on the impact of H.R. 1, the One Big Beautiful Bill Act that was passed by the United States Senate. The bill significantly cuts Medicaid...
by | Jun 30, 2025 | Lupus Foundation of America
When Jason first joined the Man Cave, a virtual Lupus Foundation of America (LFA) group for men living with lupus, his camera and mic were off, he didn’t participate in the discussion and he left early after 30 minutes.It was disheartening to see for Kevin Vaughn, a...
by | Jun 26, 2025 | Lupus Foundation of America
This year, the Lupus Foundation of America (LFA) is pleased to announce two recipients of grants supporting pediatric lupus research. This year’s recipients are Nayimisha Balmuri, MD, Assistant Professor of Pediatrics, Johns Hopkins University School of Medicine, who...
by | Jun 25, 2025 | Lupus Foundation of America, News & Events
The U.S. Food & Drug Administration (FDA) has granted approval for a new subcutaneous autoinjector formulation of belimumab (Benlysta®) treatment for children ages five years and older with active lupus nephritis (LN, lupus-related kidney disease) who are...
